跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 73,665 条关于
“PD-1/VEGF bispecific antibody”
全部
73,665
临床试验
43,816
药物
9,922
机构
1,439
资讯
18,488
2年前
Akeso's Bispecific Antibodies Show Promise in Lung and Colorectal Cancers
8个月前
AbbVie Secures $5.6 Billion Licensing Deal for Novel PD-1/VEGF Bispecific Antibody RC148
去年
Merck Expands Oncology Pipeline with $3.2B Deal for LaNova's Bispecific Antibody
去年
OncoC4 Advances PD-1/VEGF Bispecific Antibody AI-081 to Phase 2 Trial Following Promising Early Efficacy Data
10个月前
Crescent Biopharma Advances PD-1 x VEGF Bispecific Antibody CR-001 Toward Phase 1 Trial
去年
OncoC4's AI-081, a PD-1/VEGF Bispecific Antibody, Receives FDA IND Clearance for Advanced Solid Tumors
去年
LaNova Medicines Initiates Phase 1 Trial of LM-299, Anti-PD-1/VEGF Bispecific Antibody, for Advanced Solid Tumors
前天
FDA Grants Fast Track Designation to OncoC4's PD-1/VEGF Bispecific Cesalatamig for PD-(L)1-Refractory NSCLC
去年
Revolution Medicines and Summit Therapeutics Launch Clinical Collaboration to Test RAS Inhibitor Combinations with Bispecific Antibody
10个月前
Crescent Biopharma's CR-001 Bispecific Antibody Shows Cooperative Pharmacology in Preclinical Studies
第 1 页，共 1849 页
上一页
下一页
